Micrus Endovascular Corporation Market Share Analysis

Date: June 1, 2011
Pages: 76
Price:
US$ 1,000.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: M8A28D8F426EN
Leaflet:

Download PDF Leaflet

Micrus Endovascular Corporation Market Share Analysis
Micrus Endovascular Corporation Market Share Analysis

Summary

GlobalData’s new report, 'Micrus Endovascular Corporation Market Share Analysis' provides in-depth information on Micrus Endovascular Corporation’s market position in the interventional neurology market. The report also provides data and information on the overall competitive landscape within the interventional neurology market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope
  • Global company shares (in Revenues) information for the interventional neurology market.
  • Micrus Endovascular Corporation’s company shares (in Revenues) information for all the key countries the company has presence in - India, Japan, China, Australia, United Kingdom, France, Germany, Spain, Italy, United States, Canada and Brazil.
  • Micrus Endovascular Corporation’s company shares (in Revenues) information for the interventional neurology market.
  • All the key data-points are for 2010 and cover all the key regions - North America, Middle East and Africa, Europe, Asia-Pacific and South and Central America.
  • Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
  • Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any.

Reasons to buy
  • Develop sales and marketing strategies by identifying who-stands-where in the markets, Micrus Endovascular Corporation’s operates in.
  • Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
  • Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
  • Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
  • Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Micrus Endovascular Corporation’s market positions.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 What Is This Report About?

3 DEFINITIONS OF MARKETS/CATEGORIES COVERED

3.1 Interventional Neurology

4 COMPANY SNAPSHOT

4.1 Key Information
4.2 Company Overview
4.3 Financial Performance
4.4 Major Products and Services
  4.4.1 Overview

5 COMPETITORS

6 COMPETITIVE LANDSCAPE

6.1 Interventional Neurology, Global, Market Share (%), 2010

7 MICRUS ENDOVASCULAR CORPORATION MEDICAL EQUIPMENT MARKET SHARE ANALYSIS

7.1 Micrus Endovascular Corporation, Interventional Neurology, Global, Market Share (2010)
7.2 Micrus Endovascular Corporation, Asia-Pacific, Market Share (2010)
7.3 Micrus Endovascular Corporation, Europe, Market Share (2010)
7.4 Micrus Endovascular Corporation, Middle East and Africa, Market Share (2010)
7.5 Micrus Endovascular Corporation, North America, Market Share (2010)
7.6 Micrus Endovascular Corporation, South and Central America, Market Share (2010)

8 KEY EMPLOYEES

9 LOCATIONS AND SUBSIDIARIES

9.1 Head Office
9.2 Other Locations & Subsidiaries

10 FINANCIAL DEALS LANDSCAPE

10.1 Micrus Endovascular Corporation, Deals Volume Summary, 2006 to YTD 2011

11 MICRUS ENDOVASCULAR CORPORATION DETAILED DEAL SUMMARY

11.1 Partnerships
  11.1.1 Micrus Endovascular Enters Into A Licensing Agreement With Genesis Medical Interventional
  11.1.2 Micrus Endovascular Signs An Agreement With Flexible Stenting Solutions
  11.1.3 Micrus Endovascular And Chemence Medical Products Signs Development Agreement For Liquid Embolic Products
  11.1.4 Micrus Endovascular Signs An Agreement With BIOTRONIK
  11.1.5 Goodman Signs Distribution Agreement with Micrus Corporation
11.2 Equity Offering
  11.2.1 Micrus Endovascular Completes Initial Public Offering Of $38.5 Million
  11.2.2 Micrus Completes Private Placement Of $12.09 Million
11.3 Divestiture – Assets
  11.3.1 Merit Medical Acquires Cardiac And Peripheral Assets From Micrus Endovascular
11.4 Acquisition
  11.4.1 Johnson & Johnson Completes Acquisition Of Micrus Endovascular
  11.4.2 Micrus Endovascular Acquires VasCon
  11.4.3 Micrus Endovascular Acquires Neurologic UK
  11.4.4 Micrus Endovascular Acquires VascularFX

12 RECENT DEVELOPMENTS

12.1 Strategy and Business Planning
  12.1.1 Aug 24, 2009: Micrus, Flexible Stenting Solutions Sign Agreement
12.2 Financial Announcements
  12.2.1 Aug 05, 2010: Micrus Reports Net Income Of $3.1 Million For Q1 2011
  12.2.2 May 06, 2010: Micrus Reports Net Income Of $11.5 Million In Fiscal 2010
  12.2.3 Nov 04, 2009: Micrus Reports Net Income Of $3.6 Million In Q2 Fiscal 2010
  12.2.4 Aug 06, 2009: Micrus Reports Net Income Of $2.3 Million In Q1 Fiscal 2010
  12.2.5 May 07, 2009: Micrus Posts Net Loss Of $11.1 Million In Fiscal 2009
  12.2.6 Feb 05, 2009: Micrus Reports Q3 Fiscal 2009 Results
  12.2.7 Nov 06, 2008: Micrus Reports 2Q Fiscal 2009 Results
  12.2.8 Oct 06, 2008: Micrus Provides Revenue Outlook For 2Q Fiscal 2009
  12.2.9 Aug 07, 2008: Micrus Reports 1Q Fiscal 2009 Results
  12.2.10 May 08, 2008: Micrus Reports Q4 Fiscal 2008 Results
  12.2.11 Feb 07, 2008: Micrus Reports Q3 Fiscal 2008 Results
  12.2.12 Nov 08, 2007: Micrus Declares Q2 Fiscal 2008 Results
  12.2.13 Aug 07, 2007: Micrus Reports Q1 Fiscal 2008 Results
  12.2.14 May 10, 2007: Micrus Reports Q4 Fiscal 2007 Results
  12.2.15 Feb 12, 2007: Micrus Reports Q3 Fiscal 2007 Results
  12.2.16 Nov 13, 2006: Micrus Reports Q2 Fiscal 2007 Results
  12.2.17 Aug 14, 2006: Micrus Reports Q1 Fiscal 2007 Results
12.3 Corporate Communications
  12.3.1 Nov 08, 2007: Micrus Appoints CFO
  12.3.2 Sep 25, 2007: Micrus Joins NASDAQ NeuroInsights Neurotech Index
  12.3.3 Sep 24, 2007: Micrus Announces Management Changes
  12.3.4 Sep 24, 2007: Micrus Announces Management Changes
  12.3.5 Nov 20, 2006: Micrus Appoints Board Members
12.4 Legal and Regulatory
  12.4.1 Jul 12, 2010: Law Offices Of Howard G. Smith Investigates Micrus Acquisition For Shareholders
12.5 Product News
  12.5.1 Jun 17, 2010: Micrus Endovascular Receives Approval To Market DeltaPaq And DeltaPlush Microcoils In Japan
  12.5.2 May 21, 2010: Micrus Endovascular Unveils Preliminary Results Of Cerecyte Coil Trial At 48th Annual American Society Of Neuroradiology Meeting
  12.5.3 Aug 26, 2009: Micrus Endovascular To Complete Phse III Trial For PHAROS Vitesse Stent In Second Quarter Of 2011
  12.5.4 Aug 24, 2009: Micrus Endovascular And Flexible Stenting Solutions To Jointly Develops Flow Diversion Technology For Neurovascular Indications
  12.5.5 Jul 23, 2009: Micrus Endovascular Presents Results Of DeltaPaq Microcoil Study
  12.5.6 Feb 11, 2009: Micrus Endovascular Announces First Patient Enrollment In VISSIT Trial
  12.5.7 Sep 16, 2008: Micrus Endovascular Corporation Launches Neuropath Guide Catheter
  12.5.8 Jul 14, 2008: Micrus Endovascular Receives FDA Approval For Intracranial Stent Clinical Trial
  12.5.9 Jul 10, 2008: Micrus Endovascular Receives Approval To Market Cerecyte Microcoils In Japan
  12.5.10 Jun 23, 2008: Micrus Endovascular Announces CE Mark For PHAROS Vitesse Stent
  12.5.11 Jun 05, 2008: Micrus Endovascular Corporation Presents Positive Clinical Data Evaluating Cerecyte Microcoil
  12.5.12 Jan 17, 2008: Micrus Endovascular And Genesis Medical Interventional Sign License, Development And Commercialization Agreement
  12.5.13 Dec 13, 2007: Announcement Of Regulatory Approval And Launch Of SR Type Endovascular Aneurysm Embolic Coils
  12.5.14 May 16, 2006: Micrus Endovascular Receives FDA Clearance For Courier Microcatheter
  12.5.15 Mar 13, 2006: Micrus Endovascular Receives CE Mark Clearance For Courier Microcatheter And Watusi Guidewire
  12.5.16 Nov 21, 2005: Micrus Endovascular Launches Presidio Microcoil To Treat Large, Irregular Cerebral Aneurysm
12.6 Other Significant Developments
  12.6.1 Oct 27, 2008: Micrus To Present At Three Investor Conferences
  12.6.2 Aug 01, 2007: Micrus Signs Distribution Agreement With TXF Medical
  12.6.3 Jan 09, 2006: BIOTRONIK Signs Development And Distribution Agreement With Micrus

13 APPENDIX

13.1 Research Methodology
13.2 Secondary Research
13.3 Primary Research
13.4 Models
13.5 Forecasts
13.6 Expert Panels
13.7 GlobalData Consulting
13.8 Currency Conversion
13.9 Contact Us
13.10 Disclaimer 76

LIST OF TABLES

Table 1: Micrus Endovascular Corporation, Key Facts, 2010
Table 2: Interventional Neurology, Global, Company Share by Revenue ($m), 2010
Table 3: Micrus Endovascular Corporation, Interventional Neurology, Global, Revenue ($m) and Market Share (%), 2010
Table 4: Micrus Endovascular Corporation, Interventional Neurology, Asia-Pacific, Revenue ($m) and Market Share (%), 2010
Table 5: Micrus Endovascular Corporation, Interventional Neurology, Europe, Revenue ($m) and Market Share (%), 2010
Table 6: Micrus Endovascular Corporation, Interventional Neurology, Middle East and Africa, Revenue ($m) and Market Share (%), 2010
Table 7: Micrus Endovascular Corporation, Interventional Neurology, North America, Revenue ($m) and Market Share (%), 2010
Table 8: Micrus Endovascular Corporation, Interventional Neurology, South and Central America, Revenue ($m) and Market Share (%), 2010
Table 9: Micrus Endovascular Corporation, Key Employees
Table 10: Micrus Endovascular Corporation, Subsidiaries
Table 11: Micrus Endovascular Corporation, Deals Volume Summary, 2006 to YTD 2011
Table 12: Micrus Endovascular Corporation, Deals Summary, 2006 to YTD 2011
Table 13: Micrus Endovascular Enters Into A Licensing Agreement With Genesis Medical Interventional
Table 14: Micrus Endovascular Signs An Agreement With Flexible Stenting Solutions
Table 15: Micrus Endovascular And Chemence Medical Products Signs Development Agreement For Liquid Embolic Products
Table 16: Micrus Endovascular Signs An Agreement With BIOTRONIK
Table 17: Goodman Signs Distribution Agreement with Micrus Corporation
Table 18: Micrus Endovascular Completes Initial Public Offering Of $38.5 Million
Table 19: Micrus Completes Private Placement Of $12.09 Million
Table 20: Merit Medical Acquires Cardiac And Peripheral Assets From Micrus Endovascular
Table 21: Johnson & Johnson Completes Acquisition Of Micrus Endovascular
Table 22: Micrus Endovascular Acquires VasCon
Table 23: Micrus Endovascular Acquires Neurologic UK
Table 24: Micrus Endovascular Acquires VascularFX
Table 25: USD to Local Currency, Average Exchange Rate, 2010 75

LIST OF FIGURES

Figure 1: Interventional Neurology, Global, Market Share (%), 2010
Figure 2: Micrus Endovascular Corporation, Interventional Neurology, Global, Market Share (%), 2010
Figure 3: Micrus Endovascular Corporation, Interventional Neurology, Asia-Pacific, Market Share (%), 2010
Figure 4: Micrus Endovascular Corporation, Interventional Neurology, Europe, Market Share (%), 2010
Figure 5: Micrus Endovascular Corporation, Interventional Neurology, North America, Market Share (%), 2010
Figure 6: Micrus Endovascular Corporation, Interventional Neurology, South and Central America, Market Share (%), 2010
Figure 7: Micrus Endovascular Corporation, Deals Volume Summary, 2006 to YTD 2011 23

COMPANIES MENTIONED

The following companies are the major competitors of Micrus Endovascular Corporation:

AccessClosure, Inc.
Aeris Therapeutics, Inc.
B. Braun Melsungen AG
BC Tech, Inc.
Bio-Nucleonics, Inc.
Boston Scientific Corporation
CarboMedics Inc.
Cordis Corporation
Covidien plc
DePuy, Inc.
ev3 Inc.
Mizuho Ikakogyo Co., Ltd.
Target Therapeutics
Terumo Corporation

Ask Your Question

Micrus Endovascular Corporation Market Share Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: